MississippiIbogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Mar 26Approved by Governor Tate ReevesBecame Law
- Mar 19Enrolled Bill SignedTo Governor
- Mar 18Enrolled Bill Signed
- Mar 17Concurred in Amend From Senate
- Vote recorded Concurrence in Amendment From Senate. Result: pass.Lower
- Mar 12Returned For Concurrence
- Mar 10Passed As AmendedMajor
- Vote recorded Passage as Amended. Result: pass.Upper
- Mar 10AmendedMajor
- Mar 10Reconsidered
- Mar 9Motion to Reconsider Entered
- Mar 5Passed As AmendedPassed Senate
- Vote recorded Passage as Amended. Result: pass.Upper
- Mar 5AmendedMajor
- Feb 25Title Suff Do PassMinor
- Feb 13Referred To Public Health and WelfareMinor
- Jan 27Transmitted To SenateMinor
- Jan 21PassedPassed House
- Vote recorded Passage. Result: pass.Lower
- Jan 20Title Suff Do PassMinor
- Jan 8Referred To Public Health and Human ServicesIntroduced